Moxifloxacin 0.5% eye drop solution is indicated in the management of purulent bacterial conjunctivitis.
In the only study published comparing moxifloxacin to polymyxin B sulfate/trimethoprim ophthalmic solution, the former showed a greater percentage of clinical recovery after 48 hours, but not after 7 days.
Moxifloxacin has shown therapeutic equivalence to other fluoroquinolones in eye drop solution.